Summary oncoplot highlighting the main features of CDX2/UBTF ALL within the whole RNA-seq cohort. Classifying alterations, sex, age, blast percentage, and immunophenotypic classification according to European Group for the Immunological Classification of Leukaemia (EGIL); 1q gain and CXCR4 mutations are indicated. CDX2 expression is indicated in color scale from RNA-seq data. FLT3-PAN3 deletion corresponds to the 13q12.2 deletion involving FLT3 and PAN3 promoters and exon 1 (excluding 13q12.2 deletion sparing FLT3). UBTF::ATXN7L3 fusion indicates the presence of the fusion transcript as detected on RNA-seq data.